Vancouver Sun columnist Malcolm Perry visited Viva Pharmaceutical Inc. for a feature on the Fairchild Group’s banquet-benefit for VGH and UBC Hospital Foundation, and an interview with Viva’s CEO Jason Ko took place. Viva Pharmaceutical showed their support of the Foundation by donating $1.2 million to fund a first-in-Canada demonstration project for the early detection and treatment of lung cancer using innovative screening strategy and advanced computer imaging.
Viva는 폐암의 조기발견 및 치료법 개발과 이미징 신기술을 연구하는 VGH와 UBC 병원 단체에 120만달러를 기부하였습니다.
The feature was released online on Friday, July 23, and was distributed in print on Saturday, July 24 (page F2).
Edit(Aug. 01): The feature was also realized on August 1st (page H2).
Edit (Aug. 02): The event was also covered by The Province on August 2nd.